Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane serine protease 11G, pseudogene (TMPRSS11GP) is classified as a pseudogene. Pseudogenes are DNA sequences similar to known genes but usually do not encode functional proteins; therefore, TMPRSS11GP has no established biological function, disease implication, or role as a therapeutic target[3]. The TMPRSS gene family includes several protein-coding members (e.g., TMPRSS2, TMPRSS4) that are important drug targets and are involved in physiologically and pathologically relevant processes (including viral entry, cancer, and inflammation)[2][4]. However, TMPRSS11GP itself is a pseudogene and does not exhibit these functions. For any research, database queries, or structured data efforts, TMPRSS11GP should not be treated as a drug target or functional protein. If your interest concerns functional TTSPs involved in viral entry or disease, review protein-coding genes like TMPRSS2, TMPRSS4, or others in the TTSP family[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane serine protease 11G, pseudogene (TMPRSS11GP).